Jiangsu Gao Kai Precision Fluid Technology Co., Ltd. (SHA:688835)
340.47
-17.53 (-4.90%)
Sep 30, 2026, 4:00 PM EDT
SHA:688835 Revenue
Jiangsu Gao Kai Precision Fluid Technology had revenue of 327.23M CNY in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 596.26M. In the year 2025, Jiangsu Gao Kai Precision Fluid Technology had annual revenue of 510.61M with 20.66% growth.
Revenue (ttm)
596.26M
Revenue Growth
+20.66%
P/S Ratio
57.07
Revenue / Employee
902.06K
Employees
661
Market Cap
34.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 510.61M | 87.43M | 20.66% |
| Dec 31, 2024 | 423.17M | 197.46M | 87.48% |
| Dec 31, 2023 | 225.71M | 60.68M | 36.77% |
| Dec 31, 2022 | 165.03M | -11.83M | -6.69% |
| Dec 31, 2020 | 176.86M | 53.09M | 42.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kingfa Sci. & Tech. | 67.88B |
| Ningbo Joyson Electronic | 58.93B |
| Neway Valve (Suzhou) | 8.26B |
| Zhejiang Wazam New Materials Co.,LTD. | 5.23B |
| Western Superconducting Technologies | 5.11B |
| Xinjiang Daqo New Energy | 3.99B |
| APT Medical | 2.90B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.02B |